Search

everythinglearnresearchcommunity

for

Search:↓

Young men with mild hair loss who experience significant social and emotional distress are more likely to have sexual problems.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Understanding sex and gender differences can improve personalized dermatology care.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Hair loss greatly lowers perceived health in both genders, and hair transplant surgery notably improves this.

Behavior therapy and medications, especially clomipramine, can help reduce hair pulling in people with trichotillomania.

Many skin patients have mental health issues, but few dermatologists are well-versed in treating these conditions.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Cognitive-behavioral therapy is the best treatment for hair-pulling disorder, and combining it with other therapies could improve results.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Skin conditions can cause significant psychological distress, so addressing mental health is crucial for improving quality of life.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Continuous glucose monitoring and GLP-1 receptor agonists improve diabetes management, but personalized care and education are crucial.

Hair loss can cause low self-esteem, anxiety, and depression in men.

Young men's sexual dysfunction often has physical causes, which can lead to stress and worsen the problem.

People with alopecia who are more resilient tend to feel less stressed.

Genetic risk for PCOS can affect children's growth, metabolism, and development from early life into adulthood.

Burn care for the elderly needs improvement, with more research and specific guidelines required.

Myhre syndrome symptoms worsen over time, with specific genetic variants affecting severity.

A specific gene mutation is linked to a hereditary form of dystonia that responds well to certain medications.

The MATH+ protocol aims to improve COVID-19 outcomes using a combination of specific treatments.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

The new oral testosterone pill normalized testosterone levels and lowered SHBG in men with low testosterone.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.